Collaborative Research : Stochastic Modeling and Estimation of Gene Transcription
Collaborative Research : Stochastic Modeling and Estimation of Gene Transcription
批准号:
7667461
负责人:
MAREK KIMMEL
金额:
$36.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2012-06-30
关键词:
AccountingAlgorithmsApoptosisBehaviorBiologicalBiological ModelsBiologyCell membraneCellsChimeric ProteinsChromatinComplexComputational BiologyComputational algorithmComputer AnalysisComputer SimulationDataDoseEquationEukaryotic CellFamilyFluorescenceFoundationsGenetic TranscriptionGrantImmune responseIndividualMammalsMathematicsMeasurableMeasurementMedical centerMessenger RNAMethodologyMethodsModelingMolecularNF-kappa BNatural ImmunityNuclearPathway interactionsPhotobleachingPlayPopulationProcessProliferatingPropertyProtein AnalysisRNA Polymerase IIResearchResolutionRoleSignal TransductionSolutionsSourceStimulusTexasTrainingTranscriptional Regulationbasebiological systemscomputer programdesignexperienceimprovedmathematical modeloutreachreceptor bindingresearch studyresponsetheoriestooltranscription factor
中文摘要
描述(由申请人提供):单个细胞对激活刺激的反应表现出随机的变异性。在参与先天免疫反应的细胞中,这种可变性似乎非常重要。细胞对相同的刺激有不同的反应,例如,一些细胞增殖,一些细胞走向凋亡。我们的目标是开发工具来理解和准确地模拟真核细胞中基因转录和信号转导中的随机现象。该提案的一个组成部分是本科生、研究生和研究生层面的跨学科培训,我们在这方面有经验,涉及NSF IGERT补助金、凯克计算生物学中心和德克萨斯医学中心的外联。真核细胞中随机性的主要来源是:(I)吸引RNA聚合酶II的转录复合体的组装。(Ii)对于低水平的信号,结合激活分子的细胞膜受体的数量的波动。我们计划:
1.在单细胞、核和分子水平上识别基因转录和调控中随机效应的来源,并建立这些效应的数学模型。
2.研究这些模型的数学性质:(A)寻找随机解,(B)发展极限理论,(C)研究模型的定性性质。
3.开发模型预测的计算算法。为这些算法执行计算机程序。
4.应用贝叶斯和非贝叶斯统计方法估计参数并对这些参数进行推断,并评估模型的拟合优度,以便用复杂的计算机模型进行推理。
我们选择的生物系统由3条途径组成,涉及在哺乳动物天然免疫中起决定性作用的NFKB转录因子家族。这三个路径是:(I)正则路径,(Ii)RIG-IMAVS-,和(Iii)非正则路径,由不同的刺激激活,并作为计算分析随机性的信息模型。我们将通过使用荧光融合蛋白、在单个mRNA分子分辨率下分析转录、使用光漂白的染色质交换和荧光寿命测量来扩展对这些途径的理解。在我们的方法中,生物实验的动机是建模和估计所需的数据,而数学方法是基于观察到的生物模型行为。
英文摘要
DESCRIPTION (provided by applicant): Individual cells display stochastic variability in their responses to activating stimuli. In cells taking part in the innate immune response this variability seems very important. Cells react differently to the same stimulus, e.g. some proliferate some move to apoptosis. Our aim is to develop tools for understanding and accurate modeling of stochastic phenomena in gene transcription and signal transduction in eukaryotic cells. An integral part of the proposal is interdisciplinary training at the undergraduate, graduate and postgraduate level, in which we have experience, involving NSF IGERT grants, Keck Center for Computational Biology and outreach to Texas Medical Center. The primary sources of stochasticity in eukaryotic cells are: (i) Assembly of the transcription complexes attracting RNA Polymerase II. (ii) For low levels of signal, fluctuations in the number of cell membrane receptors binding activating molecule. We are planning to:
1. Identify sources of stochastic effects in gene transcription and regulation on single-cell, nuclear and molecular level and develop mathematical models of these effects.
2. Investigate the mathematical properties of these models by: (a) Finding stochastic solutions, (b) Developing limit theory, (c) Investigating qualitative properties of the models.
3. Develop computational algorithms for model predictions. Implement computer programs for these algorithms.
4. Apply Bayesian and non-Bayesian statistical methodologies for estimating parameters and making inferences about these parameters, and assess the goodness of fit of the models, for inference with complex computer models.
The biological system we chose is constituted by 3 pathways involving NFKB family of transcription factors playing a decisive role in innate immunity in mammals. These three are: (i) the canonical, (ii) the RIG-IMAVS-, and (iii) the non-canonical pathways, activated by distinct stimuli, and serve as informative models for computational analysis of stochasticity. We will extend the understanding of these pathways by using fluorescent fusion proteins, analysis of transcription at a single mRNA molecule resolution, chromatin exchange using photobleaching and fluorescence lifetime measurements. In our approach, the biological experiments are motivated by data needed for modeling and estimation, and mathematical methods are based on the observed biological model behavior.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative Research : Stochastic Modeling and Estimation of Gene Transcription
-
批准号:8053024
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2010
-
负责人:MAREK KIMMEL
-
依托单位:
Collaborative Research : Stochastic Modeling and Estimation of Gene Transcription
-
批准号:8099694
-
项目类别:
-
资助金额:$36.16万
-
财政年份:2008
-
负责人:MAREK KIMMEL
-
依托单位:
Collaborative Research : Stochastic Modeling and Estimation of Gene Transcription
-
批准号:7884326
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2008
-
负责人:MAREK KIMMEL
-
依托单位:
Collaborative Research : Stochastic Modeling and Estimation of Gene Transcription
-
批准号:7596502
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2008
-
负责人:MAREK KIMMEL
-
依托单位:
Training Program in Biostatistics for Cancer Research
-
批准号:10260489
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2003
-
负责人:MAREK KIMMEL
-
依托单位:
Training Program in Biostatistics for Cancer Research
-
批准号:10473787
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2003
-
负责人:MAREK KIMMEL
-
依托单位:
Training Program in Biostatistics for Cancer Research
-
批准号:10687082
-
项目类别:
-
资助金额:$31.63万
-
财政年份:2003
-
负责人:MAREK KIMMEL
-
依托单位:
Lung Cancer Model: Risk, Progression and Intervention
-
批准号:7290314
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
Modeling Lung Cancer: Risks, Progression, and Screening
-
批准号:6660703
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
Lung Cancer Model: Risk, Progression and Intervention
-
批准号:6961482
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
Lung Cancer Model: Risk, Progression and Intervention
-
批准号:7681603
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
Lung Cancer Model: Risk, Progression and Intervention
-
批准号:7499736
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
Lung Cancer Model: Risk, Progression and Intervention
-
批准号:7128103
-
项目类别:
-
资助金额:$21.24万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
Modeling Lung Cancer: Risks, Progression, and Screening
-
批准号:6798597
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
Modeling Lung Cancer: Risks, Progression, and Screening
-
批准号:6544982
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2002
-
负责人:MAREK KIMMEL
-
依托单位:
海外基金